Cargando…
The adaptation of the desirability of outcome ranking for interventional clinical trials in epilepsy: A novel consumer‐led outcome measure
Interventional clinical trials in epilepsy are typically designed and powered to detect a change in seizure frequency as the primary endpoint, with little consideration given to other benefits or harms of the therapy, or impacts on common epilepsy comorbidities. Desirability of outcome ranking (DOOR...
Autores principales: | Vivash, Lucy, Johns, Hannah, O'Brien, Terence J., Churilov, Leonid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690673/ https://www.ncbi.nlm.nih.gov/pubmed/37799022 http://dx.doi.org/10.1002/epi4.12839 |
Ejemplares similares
-
Applying Desirability of Outcome Ranking End Points
por: Dunne, Michael W, et al.
Publicado: (2023) -
(18)F-FDG-PET hypometabolism as a predictor of favourable outcome in epilepsy surgery: protocol for a systematic review and meta-analysis
por: Courtney, Merran R, et al.
Publicado: (2022) -
Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol
por: Vivash, Lucy, et al.
Publicado: (2023) -
1005. The Antibiotic Optimization DOOR: Refining Assessment of Antibiotic Therapy with Desirability of Outcome Ranking
por: Smoke, Steven, et al.
Publicado: (2019) -
2905. Development of a Desirability of Outcome Ranking (DOOR) for Skin Infection Clinical Trials
por: Miller, Loren G, et al.
Publicado: (2023)